Lung cancer specialist receives American Cancer Society’s Medal of Honor
Click Here to Manage Email Alerts
The American Cancer Society presented its 2024 Medal of Honor to Pasi A. Jänne, MD, PhD.
The Medal of Honor, the society’s most prestigious award, is given to individuals or foundations who made valuable contributions to basic research, clinical research, cancer control or philanthropy.
Jänne is director of Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, as well as professor at Harvard Medical School.
“In addition to Dr. Jänne’s steadfast commitment to developing more precise and durable therapies for patients with lung cancer, it is his visionary thinking, collaborative mindset, dedication to mentoring and strong leadership in oncology that earned him this recognition,” William Dahut, MD, the society’s chief scientific officer, said in a press release.
Jänne helped discover EGFR mutations and spearheaded development of treatment strategies for patients with EGFR-mutant lung cancer.
“The American Cancer Society has a longstanding history of supporting some of the most proficient cancer researchers in the world, so to be part of that group of people is an honor,” Jänne said in the release. “While we have made significant progress in lung cancer research, we owe it to patients, survivors and their caregivers to further research and advance ACS’s mission of saving more lives.”
Click Here to Manage Email Alerts